Table 2 Prevalences of protective antibodies against measles, mumps, and rubella in HIV-infected adults and HIV-uninfected controls across age groups
Age group (years) | Measles (number, %) | Mumps (number, %) | Rubella (number, %) | ||||||
|---|---|---|---|---|---|---|---|---|---|
HIV-infected adults | HIV-uninfected controls | p-value | HIV-infected adults | HIV-uninfected controls | p-value | HIV-infected adults | HIV-uninfected controls | p-value | |
20–29 | 19/24 (79.2) | 28/30 (93.3) | 0.221 | 15/24 (62.5) | 20/30 (66.7) | 0.781 | 23/24 (95.8) | 29/30 (96.7) | 1.000 |
30–39 | 186/192 (96.9) | 42/42 (100) | 0.595 | 101/192 (52.6) | 29/42 (69.1) | 0.060 | 168/192 (87.5) | 36/42 (85.7) | 0.799 |
40–49 | 170/182 (93.4) | 29/30 (96.7) | 0.699 | 95/182 (52.2) | 17/30 (56.7) | 0.697 | 142/182 (78.0) | 25/30 (83.3) | 0.634 |
50–59 | 96/102 (94.1) | 30/30 (100) | 0.336 | 64/102 (62.8) | 23/30 (76.7) | 0.192 | 90/102 (88.2) | 28/30 (93.3) | 0.736 |
Overall | 471/500 (94.2) | 129/132 (97.7) | 0.120 | 275/500 (55.0) | 89/132 (67.5) | 0.010 | 423/500 (84.6) | 118/132 (89.4) | 0.209 |